⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28262678 | 0.76 | — | — | |
| SCHEMBL643281 | 0.75 | — | — | |
| SCHEMBL11625044 | 0.72 | — | — | |
| Acetaldehyde SCHEMBL8752834 | 0.72 | — | — | |
| SCHEMBL3994471 | 0.71 | — | — | |
| SCHEMBL8509109 | 0.69 | — | — | |
| SCHEMBL10590047 | 0.69 | — | — | |
| SCHEMBL15353364 | 0.68 | TSHR (0.42) | — | |
| SCHEMBL28551726 | 0.68 | TSHR (0.42) | — | |
| SCHEMBL27362895 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2668183-B1 | IL17 AND IFN-GAMMA INHIBITION FOR THE TREATMENT OF AUTOIMMUNE INFLAMMATION | 4SC DISCOVERY GMBH (DE) | 2017-11-01 | — | — | EP | claimed |
| EP-2668183-A1 | IL17 AND IFN-GAMMA INHIBITION FOR THE TREATMENT OF AUTOIMMUNE INFLAMMATION | 4SC Discovery GmbH (DE) | 2013-12-04 | — | — | EP | claimed |
| US-8354436-B2 | IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation | 4SC DISCOVERY GMBH (DE) | 2013-01-15 | — | — | US | claimed |
| US-20120196862-A1 | IL17 AND IFN-GAMMA INHIBITION FOR THE TREATMENT OF AUTOIMMUNE INFLAMMATION | 4SC DISCOVERY GMBH (DE) | 2012-08-02 | — | — | US | claimed |
| WO-2012101263-A1 | IL17 AND IFN-GAMMA INHIBITION FOR THE TREATMENT OF AUTOIMMUNE INFLAMMATION | 4SC DISCOVERY GMBH (DE) | 2012-08-02 | — | — | WO | claimed |
| EP-0906282-A1 | HETEROCYCLYLMETHYLAMINO DERIVATIVES OF CYCLOBUTENE-3,4-DIONES AS POTASSIUM CHANNEL MODULATORS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1999-04-07 | — | — | EP | claimed |
| WO-1997048682-A1 | HETEROCYCLYLMETHYLAMINO DERIVATIVES OF CYCLOBUTENE-3,4-DIONES AS POTASSIUM CHANNEL MODULATORS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1997-12-24 | — | — | WO | claimed |
| EP-4402276-A1 | PROCESS TO PRODUCE (1 R, 4 R)-4-SUBSTITUTED CYCLOHEXANE-1-AMINES | Richter Gedeon Nyrt. (HU) | 2024-07-24 | — | — | EP | disclosed |
| US-11720019-B2 | Resist composition and pattern forming process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| WO-2023042081-A1 | PROCESS TO PRODUCE (1r,4r)-4-SUBSTITUTED CYCLOHEXANE-1-AMINES | RICHTER GEDEON NYRT. (HU) | 2023-03-23 | — | — | WO | disclosed |
| CN-112694487-B | Preparation method of cefprozil | 苏州盛达药业有限公司 | 2022-04-22 | — | — | CN | disclosed |
| US-20210278763-A1 | RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-09-09 | — | — | US | disclosed |
| CN-112694487-A | Preparation method of cefprozil | 苏州盛达药业有限公司 | 2021-04-23 | — | — | CN | disclosed |
| US-20100305100-A1 | METHODS FOR TREATING HEPATITIS C | PTC THERAPEUTICS, INC. (US) | 2010-12-02 | — | — | US | disclosed |
| US-20100292187-A1 | METHODS FOR TREATING HEPATITIS C | PTC THERAPEUTICS, INC. (US) | 2010-11-18 | — | — | US | disclosed |
| US-7772271-B2 | Methods for treating hepatitis C | PTC THERAPEUTICS, INC. (US) | 2010-08-10 | — | — | US | disclosed |
| US-20070299068-A1 | Methods for treating hepatitis C | PTC THERAPEUTICS, INC. | 2007-12-27 | — | — | US | disclosed |
| EP-0906282-A1 | HETEROCYCLYLMETHYLAMINO DERIVATIVES OF CYCLOBUTENE-3,4-DIONES AS POTASSIUM CHANNEL MODULATORS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1999-04-07 | — | — | EP | disclosed |
| CN-1040112-C | Process for preparing N-alkyl polyhydroxy amines and fatty acid amides therefrom in hydroxy solvents | PROCTER & GAMBLE (US) | 1998-10-07 | — | — | CN | disclosed |
| WO-1997048682-A1 | HETEROCYCLYLMETHYLAMINO DERIVATIVES OF CYCLOBUTENE-3,4-DIONES AS POTASSIUM CHANNEL MODULATORS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1997-12-24 | — | — | WO | disclosed |